KalVista Pharmaceuticals



KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases....

T. Andrew Crockett
Andreas Maetzel
Senior Vice President Medical
Benjamin L. Palleiko
Chief Business Officer and Chief Financial Officer
Christopher M. Yea
Chief Development Officer
Edward P. Feener
Chief Scientific Officer
Michael Smith
SVP Development

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.